Last reviewed · How we verify
NCT03151122
The Effect of a Nurse-led Continuous Support Program on Neurodevelopment of Preterm Infants
NA trial testing Nurse-led Continuous Support in Preterm Infant in 140 participants. Status unknown.
1 December 2020
Quick facts
| Lead sponsor | Wuhan University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 140 |
| Start date | 1 August 2020 |
| Primary completion | 1 December 2020 |
| Estimated completion | 1 April 2021 |
Drugs / interventions tested
- Nurse-led Continuous Support
- routine follow-up care
Conditions studied
- Preterm Infant — all drugs for Preterm Infant →
Sponsor
Wuhan University
Who can join
Adults 28 Weeks to 36 Weeks, any sex, with Preterm Infant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the study is to establish a continuous nurse-led integrated support program and to exam its impact on preterm infant neurodevelopment. Research hypotheses include:1. The continuous nurse-led integrated support will have significant impact on preterm infant neurodevelopment; 2.The support program will also have positive effect on parent psychological well-being.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03151122
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preterm Infant
Currently open trials in the same condition.
- NCT06786039 — Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants · recruiting
- NCT06532695 — Development, ADL, Participation, and Quality of Life in Preterm Infants: Longitudinal Research · recruiting
- NCT07238231 — Taiwan Preterm Infant Database: Analysis and Comparison of Birth Conditions and Exploration of Prognostic Factors · active not recruiting
- NCT03518736 — Does Timing Matter? Supporting Play, Exploration, and Early Developmental Intervention · NA · active not recruiting
- NCT03373721 — Gut Microbiota of Preterm Infants and Full-term Infants at Early Life · recruiting
Other Wuhan University trials
Trials by the same sponsor.
- NCT07381946 — High-frequency Repetitive Transcranial Magnetic Stimulation for Patients With Dysphagia After Extubation · NA · active not recruiting
- NCT06470178 — A Real-World Study of Neoadjuvant/Conversion Therapy for Colorectal Cancer With Chemotherapy And Anti-Angiogenic Targete · not yet recruiting
- NCT06464601 — A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer · not yet recruiting
- NCT06971705 — fMRI Study on Cerebral Localization and Network Mechanisms of rTMS in Chronic Ankle Instability Treatment · NA · active not recruiting
- NCT06532994 — Predictive Algorithms for Critical Rehabilitation Outcomes · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03151122 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wuhan University
- Last refreshed: 20 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03151122.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing